Alterity Therapeutics Limited
ATHE
$5.16
$0.224.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 21.74M | 20.68M | 2.81M | 3.15M | 8.43M |
| Total Receivables | 2.58M | 2.46M | 3.52M | 3.94M | 2.70M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 808.40K | 769.10K | -- | -- | 1.55M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.75M | 5.47M | 130.30K | 146.00K | 27.10K |
| Total Current Assets | 30.07M | 28.61M | 6.46M | 7.23M | 12.70M |
|
|
|||||
| Total Current Assets | 30.07M | 28.61M | 6.46M | 7.23M | 12.70M |
| Net Property, Plant & Equipment | 101.70K | 96.80K | 71.60K | 80.30K | 124.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 30.18M | 28.71M | 6.53M | 7.31M | 12.83M |
|
|
|||||
| Total Accounts Payable | 1.69M | 1.61M | 1.27M | 1.42M | 387.70K |
| Total Accrued Expenses | 1.90M | 1.80M | 363.20K | 407.00K | 3.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.90K | 41.70K | 38.80K | 43.50K | 71.50K |
| Total Finance Division Other Current Liabilities | 585.00K | 556.50K | 10.70K | 12.00K | 87.00K |
| Total Other Current Liabilities | 585.00K | 556.50K | 10.70K | 12.00K | 87.00K |
| Total Current Liabilities | 2.32M | 2.20M | 1.68M | 1.88M | 3.59M |
|
|
|||||
| Total Current Liabilities | 2.32M | 2.20M | 1.68M | 1.88M | 3.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.10K | 55.20K | 26.70K | 29.90K | 34.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.38M | 2.26M | 1.71M | 1.91M | 3.62M |
|
|
|||||
| Common Stock & APIC | 172.39M | 163.99M | 138.33M | 154.97M | 148.89M |
| Retained Earnings | -148.09M | -140.88M | -136.77M | -153.23M | -142.89M |
| Treasury Stock & Other | 3.50M | 3.33M | 3.26M | 3.66M | 3.21M |
| Total Common Equity | 27.80M | 26.45M | 4.82M | 5.40M | 9.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.80M | 26.45M | 4.82M | 5.40M | 9.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.80M | 26.45M | 4.82M | 5.40M | 9.21M |
|
|
|||||